Expression of the Hepatitis A virus empty capsids in suspension cells and transgenic tobacco plants (Nicotiana tabacum L.)

Biotecnologia Aplicada

Volumn 25, Issue 1, 2008, Pages 42-46

  López, Alina ^a   Rosabal, Yamilka ^a   Hernández, Abel ^a   González, Beatriz ^a   Ríos, Javier ^a   Pérez, Marlene ^a   Clark, Yulia ^a   Boffill, Roberto ^a   Fuentes, Alejandro ^a   Rodríguez, Licel ^b   Pentón, Eduardo ^a   Falcón, Viviana ^a   Menéndez, Ivon ^a   De La Rosa, Maria C ^a   Enríquez, Gil ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

HAV; Plant vaccine; Polyprotein; Transgenic; VLP

Indexed keywords

HEPATITIS A VACCINE; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEPATITIS A VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUSPENSION CELL CULTURE; TOBACCO; TRANSGENIC PLANT; VACCINE PRODUCTION; VIRUS CAPSID; VIRUS PARTICLE;

HEPATITIS A VIRUS; MIRIDAE; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

EID: 57149121466     PISSN: 08644551     EISSN: 10272852     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abel PP, Nelson RS, De B, Hoffmann N, Rogers SG, Fraley RT et al. Delay of disease development in transgenic plants that express the tobacco mosaic virus coat protein gene. Science 1986;232(4751):738-43.
2. Vaeck M, Reynaerts A, Hoftey H, Jansens S, DeBeuckleer M, Dean C et al. Transgenic plants protected from insect attack. Nature 1987;327:33-7.
3. De Block M, Vandewiele JM, Rao V, Dockx J, Thoen C, Gossele V et al. Engineering herbicide resistance in plants by expression of a detoxifying enzyme. EMBO J 1987;6(2):513-8.
4. Goldstein DA, Thomas JA. Biopharmaceuticals derived from genetically modified plants. QJM 2004,97(11):705-716.
5. Azhakanandam K, Weissinger SM, Nicholson JS, Qu R, Weissinger AK. Amplicon-plus targeting technology (APTT) for rapid production of a highly unstable vaccine protein in tobacco plants. Plant Mol Biol 2007;63(3):393-404.
6. Murphy FA, Fauquet CM, Bishop DH, Ghabrial SA, Jarvis AW, Martelli GP et al. Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses. Vienna & New York: Springer-Verlag, 1995.
7. Cohen JI, Rosenblum B, Ticehurst JR, Daemer RJ, Feinstone SM, Purcell RH. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci USA 1987;84(8):2497-501.
8. Cohen JI, Ticehurst JR, Feinstone SM, Rosenblum B, Purcell RH. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol 1987;61(10):3035-9.
9. Probst C, Jecht M, Gauss-Muller V. Intrinsic signals for the assembly of hepatitis A virus particles. Role of structural proteins VP4 and 2A. J Biol Chem 1999;274(8):4527-31.
10. Gauss-Muller V, Jurgensen D, Deutzmann R. Autoproteolytic cleavage of recombinant 3C proteinase of hepatitis A virus. Virology 1991;182(2):861-4.
11. Stapleton JT, Raina V, Winokur PL, Walters K, Klinzman D, Rosen E et al. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles. J Virol 1993;67(2):1080-5.
12. Stapleton JT, Rosen E, McLinden J. Detection of hepatitis A virus capsid proteins in insect cells infected with recombinant baculoviruses encoding the entire hepatitis A virus open reading frame. Baltimore: Williams & Wilkins, 1991.
13. Karayiannis P, O'Rourke S, Watts R, Waters J, Hill V, Carman WF et al. Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera. Clin Diagn Lab Immunol 1995;2(6):708-11.
14. Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 2008;105(10):3727.
15. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008;26(15):1846-54.
16. Lou XM, Yao QH, Zhang Z, Peng RH, Xiong AS, Wang HK. Expression of the Human Hepatitis B Virus Large Surface Antigen Gene in Transgenic Tomato Plants? Clin Vaccine Immunol 2007;14(4):464-9.
17. Saldana S, Esquivel GF, Olivera Flores TJ, Arias N, Lopez S, Arias C' et al. Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies. Viral Immunol 2006;19(1):42-53.
18. Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 2005;23(15):1851-8.
19. Pan L, Zhang Y, Wang Y, Wang B, Wang W, Fang Y et al. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs. Vet Immunol Immunopathol 2008;121(1-2):83-90.
20. Mas P, Balmaseda A, Delgado G, Castillo A, Comellas MM, Palomera R. Isolation of hepatitis A virus in cell culture: preliminary report. Rev Cubana Med Trop 1991;43:206-7.
21. Deblaere R, Bytebier B, De Greve H, Deboeck F, Schell J, Van Montagu M et al. Efficient octopine Ti plasmid-derived vectors for Agrobacterium-mediated gene transfer to plants. Nucleic Acids Res 1985;13(13):4777-88.
22. Hofgen R, Willmitzer L. Storage of competent cells for Agrobacterium transformation. Nucleic Acids Res 1988;16(20):9877.
23. Fuentes A, Ramos PL, Ayra C, Rodriguez M, Ramirez N, Pujol M. Development of a highly efficient system for assessing recombinant gene expression in plant cell suspensions via Agrobacterium tumefaciens transformation. Biotechnol Appl Biochem 2004;39(3):355-61.
24. Ping LH, Lemon SM. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol 1992;66(4):2208-16.
25. Spurr AR. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 1969;26(1):31-43.
26. Aguilar JC, Lobaina Y, Muzio V, Garcia D, Penton E, Iglesias E et al. Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen. Immunol Cell Biol 2004;82(5):539-46.
27. Fulford M, Keystone S. Taking A Shot at Travel Immunizations. Can J Contin Med Educ 2005;4:79-82.
28. Mason HS, Lam DM, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 1992;89(24):11745-9.
29. Youm JW, Won YS, Jeon JH, Ryu CJ, Choi YK, Kim HC et al. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice. Vaccine 2007;25(3):577-84.
30. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 2000,182(1):302-5.
31. Dus Santos MJ, Carrillo C, Ardila F, Rios RD, Franzone P, Piccone ME et al. Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 2005;23(15):1838-43.
32. Bergmann EM, Cherney MM, Mckendrick J, Frormann S, Luo C, Malcolm BA et al. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology 1999;265(1):153-63.
33. Pinto RM, Guix S, Gonzalez-Dankaart JF, Caballero S, Sanchez G, Guo KJ et al. Hepatitis A virus polyprotein processing by Escherichia coli proteases. J Gen Virol 2002;83(2):359-68.
34. Rivard D, Anguenot R, Brunelle F, Le VQ, Vezina LP, Trepanier S et al. An in-built proteinase inhibitor system for the protection of recombinant proteins recovered from transgenic plants. Plant Biotechnol J 2006;4(3):359-68.
35. Sunil Kumar GB, Ganapathi TR, Revathi CJ, Prasad KS, Bapat VA. Expression of hepatitis B surface antigen in tobacco cell suspension cultures. Protein Expr Purif 2003;32(1):10-7.
36. Biemelt S, Sonnewald U, Galmbacher P, Willmitzer L, Muller M. Production of human papilloma virus type 16 virus-like particles in transgenic plants. J Virol 2003;77(17):9211-20.
37. Van Droogenbroeck B, Cao J, Stadlmann J, Altmann F, Colanesi S, Hillmer S et al. Aberrant localization and under-glycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc Natl Acad Sci USA 2007;104(4):1430.
38. Triguero A, Cabrera G, Cremata JA, Yuen CT, Wheeler J, Ramirez NI. Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans. Plant Biotechnol J 2005;3(4):449-57.
39. Daniell H. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J 2006;1(10):1071-9.